Literature DB >> 20849922

Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration.

Tao Li1, Ying Hou, Chun-xia Yan, Teng Chen, Yan Zhao, Sheng-bing Li.   

Abstract

Locomotor sensitization is the progressive and enduring enhancement of locomotion induced by stimulants such as drugs, which alter rodent locomotion in a long-standing manner. The dopamine D3 receptor has been reported to play a role in morphine addiction. The aim of the present study was to investigate the role of dopamine D3 receptor in the morphine induced locomotor sensitization using dopamine D3 receptor knock-out mice. The dopamine D3 receptor knock-out mice did not display an enhanced behavioral response to acute morphine administration or develop an increased rate of locomotor sensitization to intermittent morphine administration. When 2mg/kg naloxone was co-administered with 10mg/kg morphine, morphine-induced locomotion sensitization in wild-type mice was significantly blocked while the locomotion in the D3 receptor knock-out mice was decreased. Then the wild-type mice were administered with dopamine D3 antagonist nafadotride. It was found that co-administration of morphine with nafadotride could effectively suppress the level of morphine induced behavioral sensitization. It was concluded that a loss of the dopamine D3 receptor gene may inhibit acute morphine induced hyperlocomotor activity and chronic morphine induced behavioral sensitization.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849922     DOI: 10.1016/j.neulet.2010.09.025

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  Increased vulnerability to cocaine in mice lacking dopamine D3 receptors.

Authors:  Rui Song; Hai-Ying Zhang; Xia Li; Guo-Hua Bi; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

2.  The selective dopamine D3 receptor antagonist, SR 21502, reduces cue-induced reinstatement of heroin seeking and heroin conditioned place preference in rats.

Authors:  Ewa Galaj; Monica Manuszak; Sandra Babic; Subramaniam Ananthan; Robert Ranaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-25       Impact factor: 4.492

3.  Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.

Authors:  Vivek Kumar; Alessandro Bonifazi; Michael P Ellenberger; Thomas M Keck; Elie Pommier; Rana Rais; Barbara S Slusher; Eliot Gardner; Zhi-Bing You; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

4.  Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.

Authors:  Yang Lv; Rong-Rong Hu; Manyi Jing; Tai-Yun Zhao; Ning Wu; Rui Song; Jin Li; Gang Hu
Journal:  Acta Pharmacol Sin       Date:  2018-09-17       Impact factor: 6.150

Review 5.  Dopamine receptors and Parkinson's disease.

Authors:  Shin Hisahara; Shun Shimohama
Journal:  Int J Med Chem       Date:  2011-06-13

6.  Dopamine receptor 3 might be an essential molecule in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors:  Yan Chen; Ying-yin Ni; Jie Liu; Jia-wei Lu; Fang Wang; Xiao-lin Wu; Ming-min Gu; Zhen-yu Lu; Zhu-gang Wang; Zhi-hua Ren
Journal:  BMC Neurosci       Date:  2013-07-31       Impact factor: 3.288

7.  The Role of Dopamine D1 and D3 Receptors in N-Methyl-D-Aspartate (NMDA)/GlycineB Site-Regulated Complex Cognitive Behaviors following Repeated Morphine Administration.

Authors:  Yunpeng Wang; Fangyuan Yin; Hao Guo; Jing Zhang; Peng Yan; Jianghua Lai
Journal:  Int J Neuropsychopharmacol       Date:  2017-07-01       Impact factor: 5.176

8.  Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.

Authors:  Kori L Brewer; Christine A Baran; Brian R Whitfield; A Marley Jensen; Stefan Clemens
Journal:  Front Neural Circuits       Date:  2014-06-11       Impact factor: 3.492

Review 9.  Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.

Authors:  Ewa Galaj; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2020-05-03       Impact factor: 8.989

10.  Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.

Authors:  Jian Huang; Genmeng Yang; Zhen Li; Chi-Kwan Leung; Wenguang Wang; Yuanyuan Li; Liu Liu; Baoyu Shen; Cuihua He; Yongwang He; Xiaofeng Zeng; Juan Li
Journal:  Brain Behav       Date:  2020-01-14       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.